pfama-1-fvo[25-545]
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00730782)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pfama-1-fvo[25-545]
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00730782 | Phase 1 | Nov 1, 2005 | Biomedical Primate Research Centre, European Malaria Vaccine Initiative, GlaxoSmithKline, Radboud University, SEPPIC, Paris |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomedical Primate Research Centre | Academic/Hospital | 1 | 0 | 1 | 2005 |
| European Malaria Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2005 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2005 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| SEPPIC, Paris | For profit | 1 | 0 | 1 | 2005 |
5 organizations
Page 1 / 1